Skip to main content

Month: September 2023

Signature of a Three-Party MOU on the Commercialization of Novacium’s Hydrogen Production System

MONTREAL, Sept. 26, 2023 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials is pleased to announce that HPQ and its Lyon-based affiliate, Novacium SAS, have signed a three-party memorandum of understanding (MOU) with LN INNOV’ SAS of Toulouse, France. LN INNOV’ is a French networking company with a strong presence in various sectors, including Defense. Leveraging its extensive network, LN INNOV’ aims to streamline access to innovative energy projects like the one presented by Novacium and HPQ. Their goal is to connect key industry stakeholders and expedite the transition of innovative projects from the research and development phase to commercialization. “France has set the goal...

Continue reading

Alpine Income Property Trust Announces Third Quarter 2023 Earnings Release and Conference Call Information

WINTER PARK, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for the third quarter of 2023 after the market closes on Thursday, October 19, 2023. A conference call to discuss its financial and operating results is scheduled for Friday, October 20, 2023 at 9:00 AM ET. A live webcast of the call will be available on the Investor Relations page of the Company’s website at www.alpinereit.com or at the link provided in the event details below. To access the call by phone, please go to the link provided in the event details below and you will be provided with dial-in details.Event Details:  Webcast: https://edge.media-server.com/mmc/p/fg68mtir  Dial-In: https://register.vevent.com/register/BI7fdbafb88c2e4305bc44b67274dc0cca     We...

Continue reading

Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa

CLEVELAND, Sept. 26, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the Company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of EB-101, its investigational autologous, engineered cell therapy, as a treatment for patients with recessive dystrophic epidermolysis bullosa (RDEB). As part of the submission, Abeona requested a Priority Review, which, if granted, would shorten the FDA’s review period to six months from the filing acceptance of the BLA, instead of 10 months under standard review. “The BLA submission for EB-101 is a historic milestone for Abeona and a critical step toward making our investigational EB-101 product an option for RDEB patients as the first individualized cell therapy with potential to provide years of wound...

Continue reading

Green Ammonia Market Size Outlook [2023-2030] | Industry Growth, Share, And Trends Forecast Analysis Report

Green Ammonia Market Major Manufacturers Covered in The Market Report Include: BASF, Siemens, Yara International, Green Hydrogen Systems, ITM Power, EXYTRON GmbH, MAN Energy Solutions, Haldor Topsoe A/S, Aquahydrex, Inc, Starfire Energy, Electrochaea, and ThyssenKrupp. Pune, India, Sept. 26, 2023 (GLOBE NEWSWIRE) — The global green ammonia market update 2023 forecasts global green ammonia market size, share and growth from 2023 to 2030. It’s also discusses key growth and restraining factors that are impacting the growth of projections for forecast period. The global green ammonia market size is set to gain momentum from emerging regulations and directions regarding the carbon emission of industries and taking up green ammonia production as an alternative for carbon. This information is given by Fortune Business Insights™...

Continue reading

Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova

Proposed acquisition adds market leading magnetic mixing technology for upstream and downstream bioprocess applications Expands Repligen’s Fluid Management portfolio, complements single-use bag offeringWALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a definitive agreement to acquire privately-held Metenova AB (Metenova) of Mölndal, Sweden. Metenova is projected to generate revenues of $24 million to $25 million for fiscal year 2023, led by the success of its magnetic mixing and drive train technologies that are widely used by global biopharmaceutical companies and contract development and manufacturing organizations (CDMOs). The company recently entered the single-use mixing market...

Continue reading

Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates

Q3 2023 consolidated revenue of $20.9 million, adjusted EBITDA of $2.2 million sBLA for F8 formulation of tesamorelin submitted to FDA Agreement in principle on key amendments to loan facility with MarathonMONTREAL, Sept. 26, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today reported business highlights and financial results for the third quarter and first nine months of fiscal year 2023, ended August 31, 2023. All figures are in U.S. dollars unless otherwise stated. “Theratechnologies’ reported quarterly revenue of $21 million, demonstrating a solid recovery as compared to the prior quarter. While new prescription growth continues on a strong path, we also...

Continue reading

Suspicion regarding two employees of the Iru power plant

Today, the Economic Crimes Bureau of the Estonian Police and Border Guard Board detained two long-term employees of the Iru power plant owned by Enefit Green on suspicion of violating the procedure for conducting public procurements (§ 300 (1) of the Penal Code). The employment relationship with these employees is in the process of being terminated. The proceedings started with an internal investigation initiated by Enefit Green’s Internal Audit Department and the matter was transferred to the Economic Crimes Bureau of Estonian Police and Border Guard Board upon the appearance of sufficient evidence. Innar Kaasik, Member of the Management Board and Head of Production at Enefit Green, notes that the company has zero tolerance for illegal behaviour and behaviour that is not aligned with company’s values. “We have built a functioning...

Continue reading

Victoria’s Secret Presents: The Tour ’23 – Now Streaming on Prime Video

Victoria’s Secret invites audiences worldwide to embark on a captivating fashion journey with “The Tour ’23,” now streaming on Prime Video Customers can shop Victoria’s Secret’s Tour-inspired products on VictoriasSecret.com and in the Amazon Fashion store REYNOLDSBURG, Ohio, Sept. 26, 2023 (GLOBE NEWSWIRE) — Victoria’s Secret is thrilled to announce that Victoria’s Secret: The Tour’23 is now available to stream on Prime Video. Part documentary, part spectacular fashion event – the exclusive showcase will captivate audiences and provide a viewing experience that celebrates Victoria’s Secret’s mission to uplift and champion women all over the world. The reimagined fashion show takes Prime Video viewers on a journey through the creation of The Tour, with behind-the-scenes footage and intimate stories of the VS20 – a group of 20 innovative...

Continue reading

Leading Industry Energy Research Association Chooses Draganfly Commander 3XL Platform for Inspection Standards Operations

Draganfly is recognized as an NDAA-compliant, North American-developed drone provider. Los Angeles, CA., Sept. 26, 2023 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased that a leading energy research association has chosen Draganfly’s Commander 3XL Platform for inspection standards operations. U.S.-based energy organizations require NDAA (National Defense Authorization Act) compliant drones primarily for security and regulatory protocols. The NDAA compliance ensures that these drones are not equipped with components or manufactured by entities deemed to pose a national security risk. Being recognized as an NDAA-compliant, North American-developed drone provider is a significant distinction...

Continue reading

Nova Leap Health Corp. to Discuss Record Q2 Results and Present at the LD Micro Main Event

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Sept. 26, 2023 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce that Chris Dobbin, President & CEO of Nova Leap, will present at the upcoming LD Micro Main Event XVI Conference to be held October 3-5, 2023 at the Luxe Sunset Boulevard in Los Angeles, CA. The conference will bring together the most promising companies and top investors in microcap finance for three days of presentations and one-on-one meetings.   Mr. Dobbin will be presenting at the event by way of webcast on Tuesday, October 3, 2023 at 4:00 PM Eastern Time / (1:00 PM Pacific Time). The presentation will be live-streamed at the following link: https://me23.sequireevents.com/ The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.